Chinese Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8) (CLDEQ-8)
Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8) Among Chinese Soft Contact Lens Wearers
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age between 18-60
- Native Chinese citizens with Chinese as first language
- Wearing history with spherical disposable SCL (daily disposable, 2 weeks, or monthly disposable) for a least 1 months;
- Willing to sign informed consent
Exclusion Criteria:
- Any extended wear of SCLs, including wearing toric or multi-focal SCLs
- Use SCL for monovision correction
- Having clinically significant anterior segment abnormalities (including iritis and infection of the eye, lids, or ocular adnexa)
- Having ocular or systemic disease that would preclude SCL wearing
- Best corrected visual acuity of less than 0.8 in either eye
- History of refractive or other types of corneal surgeries
- Having eyelid abnormalities or functional ocular disorders that would induce relevant discomfort.
8) Having congenital or systemic conditions that would limit the capacity to answer the questionnaire
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The reliability of the C-CLDEQ-8
Time Frame: before the ocular examination
|
Subjects are asked to complete C-CLDEQ-8.
Internal consistency (reliability) of the C-CLDEQ-8 is evaluated using the Cronbach's Alpha analysis and the corrected index of homogeneity.
For Cronbach´s Alpha results: < 0.5 is considered unacceptable; 0.5-0.6 poor; 0.6-0.7 questionable; 0.7-0.8
acceptable; 0.8-0.9
good; and > 0.9 excellent.
|
before the ocular examination
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The repeatability of the C-CLDEQ-8
Time Frame: before and after the ocular examination on the same day of visit
|
a subgroup of 50 participants are asked to complete C-CLDEQ-8 twice.
Intraclasss correlation coefficient between the two scores of the first and second questionnaire evaluation is used to evaluate the repeatability.
>0.7 is considered reliable.
|
before and after the ocular examination on the same day of visit
|
|
Cutoff score for C-CLDEQ-8 to predict "Excellent/Very Good" overall of SCLs.
Time Frame: before the ocular examination
|
The Youden-index method is used to determine the cutoff value of the C-CLDEQ-8 score that maximized sensitivity+specificity -1.
|
before the ocular examination
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022KYPJ100
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.